Integra Codman Bactiseal Catheter System, Large, Barium, 15cm Ventricular Catheters, 120cm Peritoneal Catheter

Description

Integra Codman Bactiseal Shunt Catheter System

For use in the treatment of hydrocephalus as a component of a shunt system when draining or shunting of cerebrospinal fluid (CSF) is indicated.

Product Code: NS5075

• 15cm Ventricular Catheter REF NS5073
• 120cm Peritoneal Catheter REF NS5074
• Stainless Steel Stylet
• Right-Angled Adapter
• Large Barium .060”x.120”

Sterilization

• Device Packaged as Sterile: Yes
• Requires Sterilization Prior to Use: No 
• Single-Use
• Disposable

Additional Details

• Company Name: Integra Lifesciences Production Corporation
• FDA Product Code: HCA
• FDA Product Code Name: Catheter, Ventricular 
• FDA Product Code: JXG
• FDA Product Code Name: Shunt, central nervous system and components 
• GMDN Term Code: 61376
• GMDN Term Name: Intracerebral infusion/drainage catheter, long-term
• GMDN Term Definition: A sterile, flexible tube intended to be surgically inserted through the skull for long-term (> 30 days) subdural access to the brain (e.g., cerebral ventricles, cystic tumours) for cerebrospinal fluid (CSF) drainage and/or infusion of materials (e.g., chemotherapeutic agents); it is typically used for measurement of intracranial pressure (ICP) and as part of a shunt system. It may include an attached port/reservoir at its proximal end that is placed subcutaneously to facilitate material infusion/collection, and/or accessory devices intended to facilitate catheter introduction and/or stabilization (e.g., stylet, catheter holder); it does not include a sensor. This is a single-use device.
• GMDN Term Code: 61159
• GMDN Term Name: Peritoneal/atrial cerebrospinal fluid catheter
• GMDN Term Definition: A flexible tube intended to be implanted as the distal component of a ventriculo-peritoneal/atrial shunt, to channel cerebrospinal fluid (CSF) to either the peritoneal cavity or the right atrium (i.e., dual-capability) where it can be absorbed into the body. It is intended to be part of a therapeutic measure for situations where excess CSF causes elevated intracranial pressure (hydrocephalus). Disposable devices associated with implantation may be included.

Additional information